February 26, 2013 — New and updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition are now available via the latest version of the American College of Radiology appropriateness criteria. These continually updated criteria are a national standard developed by expert panels of physicians from many different medical specialties.

In the latest version, the ACR updated 23 appropriateness criteria topics and added four new criteria — pulmonary hypertension; renal transplant dysfunction; management of locoregionally advanced squamous cell carcinoma of the vulva; and treatment of Stage I T1 glottic cancer. ACR appropriateness criteria guide physicians when ordering exams and help ensure that patients get the right scan or therapy for the right indication. The criteria have also been shown to improve quality, reduce unnecessary exams and lower costs. 

“Choosing the most appropriate radiation therapy strategy is essential to the effective and safe treatment of many cancer patients. Use of ACR appropriateness criteria can aid physicians in doing so by providing the latest evidence-based approach for a wide variety of radiotherapy issues,” said Benjamin Movsas, M.D., FACR, chair of the ACR Committee on Radiation Oncology Appropriateness Criteria.

ACR appropriateness criteria provide a tool for more effective clinical decision making to help ensure that imaging is neither over nor underutilized. The guidelines are developed by expert panels in diagnostic imaging, interventional radiology and radiation oncology. Each panel includes leaders in radiology and other specialties. Currently, there are 186 topics with over 900 variants available.

“ACR appropriateness criteria are the most comprehensive evidence-based guidelines available for selection of diagnostic imaging and image-guided interventional procedures. Not only do these guidelines aid referring physicians and other providers in choosing the most appropriate diagnostic imaging and interventional procedures for a wide variety of clinical conditions, they can reduce unnecessary patient and population exposure to radiation, a growing concern of many Americans. I urge every provider to familiarize themselves with these guidelines before making a diagnostic imaging or image-guided interventional treatment decision,” said E. Kent Yucel, M.D., FACR, chair of the ACR Committee on Diagnostic Imaging and Interventional Radiology Appropriateness Criteria.

For more information: acr.org/Quality-Safety/Appropriateness-Criteria

 

 


Related Content

News | Magnetic Resonance Imaging (MRI)

April 27 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | Computed Tomography (CT)

April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time April 30, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Radiology Business

April 28, 2026 — The American Society of Radiologic Technologists will award Life Member status to three longstanding ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Radiology Business

April 24, 2026 — The 2026 vacancy rate for radiation therapists decreased to 11.4% and the vacancy rate for medical ...

Time April 24, 2026
arrow
News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
Subscribe Now